As Trump Promotes CBD, Should You Buy, Sell, or Hold Canopy Growth Stock?

Canopy Growth (CGC) shares soared about 18% on Monday after President Donald Trump endorsed cannabidiol (CBD) as a potential breakthrough in senior healthcare. CBD could “revolutionize senior healthcare,” Trump wrote on Truth Social over the weekend, reigniting speculation that marijuana may be reclassified under his administration. More News from Barchart Including today’s rally, Canopy Growth stock is up a little over 100% versus its year-to-date low. www.barchart.com Why Trump’s Social Media Post I ...